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Abstract 
The marked radiosensitivity of renal tissue repre-
sents a limitation on the total radiotherapeutic dose that 
safely can be applied to treatment volumes that include 
the kidneys. Radiation nephropathy is characterized by 
a progressive reduction in renal hemodynamics associ-
ated with a severe anemia. The latter is often normo-
chromic normocytic in character, but can progress to a 
microangiopathic hemolytic anemia. The pathogenic 
mechanisms responsible for the development of radiation 
nephropathy remain ill-defined. Experimental studies 
which allow serial determinations of functional, morpho-
logic, and cell kinetic radiation-induced changes indicate 
that primarily glomerular but also tubular alterations 
occur in the primary stages of radiation nephropathy. 
Glomerular capillary endothelial cell loss is seen within 
several weeks of irradiation. Remaining endothelial 
cells exhibit increased permeability leading to a subendo-
thelial transudate. Mesangiolysis also is observed. In 
contrast, podocytes appear to be relatively unaffected at 
this stage. The endothelial changes appear to resolve, 
but the mesangial lesions progress, with hypercellularity 
and/or hypertrophy, increased mesangial matrix, mesan-
gial sclerosis, and ultimately, glomerulosclerosis. These 
mesangial changes are similar to those observed in other 
chronic glomerulopathies. Dietary protein restriction, 
corticosteroids, and ACE-inhibitors all can reduce the 
severity of experimental radiation nephropathy. 
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Introduction 
Since the earliest reports describing the effects of 
X-rays on the kidney [12], there have been conflicting 
views concerning the relative sensitivity of the organ, 
particularly the specific components of the nephron, to 
radiation. Some authors considered the kidney to be ra-
dioresistant [93, 94], leading to statements such as this 
by McQuarrie and Whipple [118]: "We feel confident 
that the clinician may use the X-rays over the kidney 
areas with confidence that renal tissue is resistant to the 
hard Roentgen rays." Others inferred from experimental 
observations that patients who had impaired renal func-
tion, or whose kidneys were "under special stress", 
should not be treated with radiation or should be fol-
lowed up closely after X-ray exposure [48]. Not until 
the excellent experimental studies by Hartman et al. [65, 
66], confirmed in a later clinical report [43], was it uni-
versally appreciated that renal tissue was radiosensitive. 
Indeed, from the standpoint of serious or fatal damage, 
the kidneys are probably the most radiosensitive of the 
abdominal organs [16]. 
This marked radiosensitivity frequently limits the 
total dose that can be safely applied to treatment vol-
umes in which the kidneys are included. The classic 
study of Kunkler et al. [96] defined the clinical radiation 
tolerance of the kidney by studying a number of patients 
who had received bilateral renal irradiation with 250 kV 
X-rays during the treatment of testicular tumors. They 
established that a total dose of 23 Gy, given over a 5 
week period, carried with it a high risk of renal damage. 
More recently, a tolerance dose of some 20 Gy has been 
proposed [95]. The recognition of this, and subsequent 
improvements in radiotherapeutic practice, have allowed 
radiation oncologists to reduce the radiation dose to 
which the kidney is exposed during irradiation for malig-
nancies. This has resulted in a low incidence of radia-
tion-induced renal morbidity (radiation nephropathy) in 
patients. A review of clinical accounts of renal radiation 
injury revealed the existence, by 1964, of only 120 cases 
[123]. However, the recent development of total body 
irradiation (TBI) for bone marrow ablation, as a prereq-
uisite to hone marrow transplantation (BMT), has led to 
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Figure 1. A nephrectomy specimen in which segmental, 
arcuate, and intralobular arteries show occlusive intimal 
thickening (arrows - internal elastic lamina) which 
caused renovascular hypertension in a 5-year-old, 2 
years following intraoperative irradiation (dose un-
known) for adrenal neuroblastoma. Elastic van Gieson. 
Bar= 50 µm. 
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a number of reports of radiation nephropathy in long-
term survivors of BMT [9, 14, 29 , 32, 73, 84, 102, 
105, 188, 191]. Thus, the risk of radiation nephropathy 
remains a limiting factor in clinical radiotherapy. 
Clinical Pattern of Radiation-Induced 
Damage to the Kidney 
Warthin [194] was the first to report autopsy find-
ings in kidneys of 2 leukemic patients who received ra-
diation. He described fatty degeneration, necrosis, and 
extensive calcification of renal tubules. However, it ap-
pears that these changes were instead those of acute uric 
acid nephropathy or the so-called tumor lysis syndrome 
[31, 130]. Probably the first accurate description of ra-
diation-induced renal damage in a patient was published 
in 1927. Domagk [ 42] described a 9-year-old girl who 
received abdominal irradiation for tuberculous mesen-
teric lymph nodes; she died 6 months later with symp-
toms of renal failure. At the time of the autopsy, the 
kidneys were small and showed glomerular hyalinization 
or thickening of the Bowman's capsule, tubular atrophy 
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or necrosis, and hyaline material in arterial walls. In 
the following years, there were several reports of radia-
tion-induced renal injury (for reviews see [63, 145]), but 
it was Luxton [106, 107, 108], who, in a close follow-
up of 58 patients arising from the irradiation study of 
Kunkler et al. [96], first classified the lesions into five 
categories: acute radiation nephritis, chronic radiation 
nephritis, proteinuria, benign hypertension, and malig-
nant hypertension. Since, these "categories" overlap, 
individual cases may go through several of these phases 
during the course of developing renal damage. 
Acute radiation nephritis (ARN) ARN usually 
presents after a latent period of 6-12 months in adults 
(so it is not acute in the usual sense), but may develop 
earlier in children [209, 210]. The clinical picture is 
one of edema, dyspnea, headaches, and moderate hyper-
tension. A normochromic normocytic anemia may de-
velop; in severe cases, a microangiopathic hemolytic 
anemia may develop, fragmented red blood cells (schis-
tocytes) may be detectable, and thrombocytopenia and 
purpura may arise later. The development of anemia is 
indicative of severe later changes and implies a poor 
prognosis. The symptoms and physiological alterations 
are usually moderate, but may develop into severe ma-
lignant hypertension. Of 22 patients developing ARN, 
12 died from the effects of renal irradiation; all that 
survived for an average of 16 years after radiotherapy 
had decreased renal function that progressed to chronic 
radiation nephritis. 
Chronic radiation nephritis (CRN) CRN may 
evolve from ARN or develop in patients who have had 
no previous history of ARN. Although it appeared ini-
tially that the prognosis of these latter patients was 
better, more prolonged follow-up indicated no significant 
difference in the long-term survival of the two groups 
[107] . The clinical symptoms of CRN are albuminuria, 
hypertension, and a reduction in renal function. Anemia 
may develop. 
Benign hypertension Benign hypertension may de-
velop within 2-5 years of the completion of therapy, and 
may persist for several years. Patients exhibit the usual 
complications associated with hypertension and may suc-
cumb to cardiovascular complications. 
Late malignant hypertension Late malignant hy-
pertension may evolve from ARN or CRN and be asso-
ciated with radiation nephropathy. It also may develop 
after irradiation of one kidney and can be relieved by 
removing the irradiated kidney. 
Proteinuria Proteinuria, either intermittent or per-
manent, may develop after an average interval of 11 
years following radiotherapy. Although renal function 
in these patients appears normal , they seem to have an 
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impaired renal reserve and exhibit temporary renal 
failure after stress. 
Three alternative terms were proposed by Mostofi 
[123] who evaluated a number of human cases compiled 
from the Armed Forces Institute of Pathology files: 
nephroendotheliosis, sclerosing nephrosis, and nephro-
glomerulosis; these correspond to Luxton's proteinuria, 
CRN, and ARN, respectively. However, this terminolo-
gy has not been widely adopted by workers in the field. 
It also should be noted that the term "radiation nephritis" 
(ARN and CRN) is a misnomer. There is no acute renal 
Figure 2. Renal biopsies from three BMT patients 
treated with TBI (12 Gy) and multi-agent chemotherapy. 
Each micrograph shows a glomerulus from a different 
patient: (A) 14 months postirradiation showing florid ex-
pansion of the subendothelial space (arrow) and mesan-
giolysis (M), Jones methenamine silver; (B) 12 months 
postirradiation showing widespread capillary loop redu-
plication (arrow) and focal thrombosis (curved arrow), 
Jones methenamine silver; and (C) 5 months postirradia-
tion showing glomerular capillary loop thrombosis with 
mesangial extravasation and fragmentation of red blood 
cells, hematoxylin and eosin. Bars 10 µm. 
inflammation observed immediately after irradiation. 
Moreover, inflammatory exudate is uncommon in ir-
radiated kidneys. More recently, the term radiation 
nephropathy has been used to describe the functional 
and pathological changes noted following irradiation of 
the kidney [36, 51, 198]. The clinical features of 
patients exhibiting radiation nephropathy include a 
reduction in renal hemodynamics, an increase in serum 
creatinine and BUN, anemia (normochromic, normo-
cytic, or hemolytic), proteinuria, and hypertension. 
Functional changes 
The early investigations into the effects of radiation 
on renal function have been reviewed extensively else-
where [63, 145] and will not be discussed here. There 
have been relatively few detailed clinical reports of the 
consequences of radiation on renal function, due to the 
practical limitations of a prolonged follow-up of patients. 
Avioli et al. [11] specifically addressed the problem of 
acute and chronic changes in 10 patients who had histo-
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Figure 3. Renal biopsies from two BMT patients obtained 14 and 5 months, respectively, after treatment with total 
body irradiation (12 Gy) and multiagent chemotherapy. (A) A glomerular capillary showing subendothelial expansion 
and a thin layer of new basement membrane (arrow). (B) A glomerular capillary showing endothelial cell denudation 
(arrow), thrombosis, and fragmented red blood cells. Bars = 2 µm. 
logically confirmed intra-abdominal and/or retroperi-
toneal malignancies with no evidence of renal disease. 
Standard clinical assays, such as BUN levels, urinalysis, 
and IVP examination, showed few changes. However, 
more detailed studies showed reductions in glomerular 
filtration rate (GFR) and renal blood flow, both during 
and after the completion of radiotherapy. Indeed, there 
was a progressive decline in GFR up to 12 months after 
irradiation. Thus, during the latent period, subtle sub-
clinical alterations in renal function occurred before the 
clinical expression of injury. Other studies have con-
firmed the poor diagnostic value of routine renal func-
tion tests. When a more accurate monitoring of the 
functional status has been carried out, e.g., using 
renography or scintigraphic techniques, similar acute and 
long-term changes in renal function have been identified 
[11, 40, 88, 89, 103, 142). This radiation-induced 
reduction in renal function appears to be progressive in 
nature [41). However, there have been reports indicat-
ing either some recovery in function or a stabilization of 
renal function, albeit at levels significantly lower than 
those observed prior to radiation [33). 
In contrast to these limited clinical data, there is a 
wealth of experimental data on radiation nephropathy. 
As observed clinically, initial findings in rodents indi-
cated a latent period of some 6 months before any ap-
parent change in renal function [25, 30, 200]. In con-
trast, studies using large animals such as the monkey [5, 
144, 157), pig [148, 150], and dog [34, 120], have re-
ported pronounced changes in GFR and ERPF within 
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several weeks of radiation. These observations have 
been interpreted to be indicative of species differences in 
radiation sensitivity. However, recent studies, using 
more sensitive indices of renal function, have shown that 
early radiation-induced changes in renal function also are 
evident in mice and rats [38, 79, 177). There is some 
evidence for an initial hyperemic response [144, 148, 
177), also seen clinically [11, 189]. This is followed by 
a dose-dependent progressive decline in both GFR and 
ERPF, evident within some 6-8 weeks of irradiation. 
Minimal levels are observed approximately 12-16 weeks 
after irradiation; renal function then might continue to 
decline, might plateau, or might show an apparent 
recovery in function, depending on the radiation dose 
administered. It should be noted that a recovery in GFR 
and ERPF might be more apparent than real. Renal 
function might increase as a result of cellular hypertro-
phy rather than as a result of cellular repair or repopula-
tion. The use of functional parameters, such as GFR 
and ERPF, that measure the overall functional capacity, 
cannot distinguish between these two possibilities. Re-
cent studies in the pig have indicated that the overall 
time-sequence of changes in GFR and ERPF observed 
following unilateral [148, 149] or bilateral radiation 
[150), or radiation of a single hypertrophied kidney 
[152], is essentially the same. Indeed, a similar pattern 
of response has been seen following renal irradiation in 
the monkey [157] and rat [24]. This implies a common 
response to radiation, a response which is independent 
of any variation in the status of the renal tissue prior to 
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Figure 4. A renal biopsy from a BMT patient taken 5 months after total body irradiation (12 Gy) and multiagent 
chemotherapy. (A) A glomerulus with a large acellular tuft and collapsed capillary loops. Note residual podocytes 
(arrow) and adjacent arteriolar thrombosis (curved arrow). Hematoxylin and eosin. Bar = 10 µm. (B) Ultrastructural 
examination of a collapsed segment shows absent endothelial cells (arrow) and scant residual mesangial cell processes 
(curved arrow). Podocytes remain but have lost their foot processes. Bar = 2 µm. 
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irradiation. Thus, it is likely that common patho-
physiological mechanisms are involved. What does 
differ in the various experimental situations is the 
severity of the radiation-induced decline in renal 
function, and the degree of improvement seen from 
around 16 weeks onwards. 
These radiation-induced changes in renal hemody-
namics are associated with a severe normochromic nor-
mocytic anemia [108, 150]; in some cases, this might 
progress to a microangiopathic hemolytic anemia [14, 
33, 188]. The severity of the anemia is disproportionate 
to the degree of azotemia. Two mechanisms have been 
proposed to account for this radiation-induced anemia: 
hemolysis, and/or a reduction/inhibition in erythropoietin 
(Epo) production. · Down et al. [45] noted a marked 
anemia in mice following TBI, with fragmented erythro-
cytes and reticulolysis. Later studies indicated a reduced 
erythrocyte life-span, with no apparent alteration in 
erythropoiesis [46]. Similar hemolytic changes have 
been seen clinically [14, 33, 188]. The critical site for 
initiating a microangiopathic hemolysis is believed to be 
the glomerular capillary tufts, which do indeed demon-
strate marked disruption following irradiation [36, 51, 
210]. In contrast, Luxton [108] stated that the severity 
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of the anemia observed in radiation nephropathy implied 
that irradiation interfered with the production of Epo in 
the kidney, a conclusion reached earlier in experimental 
studies using the mouse [135, 136] and the dog [53]. 
Detailed blood analyses performed in the pig [150] 
showed that localized irradiation of both kidneys resulted 
in a normochromic normocytic anemia. Moreover, a 
low absolute reticulocyte count was noted, indicating that 
the anemia represented inhibition of erythrocyte produc-
tion. Low plasma Epo levels have been reported in pa-
tients exhibiting anemia following TBI [33]. This re-
duced production has been interpreted as indicating dam-
age to the juxtaglomerular apparatus [4]. The localiz.a-
tion of these Epo-producing cells has been the focus of 
intense investigation. Glomerular [23, 28, 92, 97] and 
tubular [98] cells have been reported to be primary sites 
of Epo production. More recently, studies using 35S-la-
beled antisense RNA probes specific for mRNA coding 
for Epo have identified interstitial peritubular cells, pre-
dominantly located in the cortical labyrinth, as the site 
of Epo synthesis [47]. It is likely that both hemolysis 
and a decreased Epo production play a role in the devel-
opment of a radiation-induced anemia. The importance 
of the latter has been demonstrated clinically by the sue-
M.E.C. Robbins and S.M. Bonsib 
cessful treatment of anemia using parenteral Epo [33]. 
Morphologic Changes 
The marked radiosensitivity of the kidneys is now 
clearly recognized, and the clinical characteristics of ra-
diation nephropathy have been well described. Studies 
of changes in renal morphology, ideally, should help as-
certain the cell type(s) at risk and, in conjunction with 
the observed functional data, provide a rational basis for 
an understanding of both the pathogenesis of radiation 
nephropathy and the use of interventional procedures di-
rected at ameliorating the severity of this lesion. Clini-
cal pathological studies have been reported (for review 
see [36]) but are limited by the fact that damaged kid-
neys seldom are evaluated before the pathological proc-
ess is well advanced, thereby precluding accurate deter-
mination of primary structural alterations. Furthermore, 
much of the literature is from BMT patients in which 
nephrotoxic chemotherapeutic drugs may contribute to 
the renal injury. Experimental investigations on the 
morphologic changes seen following irradiation have 
yielded conflicting results. A number of earlier investi-
gators [124], as well as recent authors [67, 81, 119, 
121, 139, 203] have indicated that tubular damage is an 
early and prominent morphologic alteration in the irradi-
ated kidney. Other authors have reported that glomeru-
larlesions [35, 62, 64, 75, 76, 109, 110, 111, 129, 154, 
159, 176] or vascular changes [115, 162, 193] are pri-
marily evident. This lack of agreement has been as-
cribed to differences in the doses of radiation used, 
physiological status of the kidney at the time of radia-
tion, the amount of kidney exposed, and the interval 
from radiation to morphologic evaluation; few serial sac-
rifice studies have been performed. Although species 
differences also have been implicated [124], we are of 
the opinion that these are of minimal importance. An-
other factor is the use of insufficiently sensitive histolog-
ical methods. Electron microscopy studies may reveal 
changes not readily visible at a particular time-point 
using conventional light microscopy, and the use of spe-
cific stains helps to identify particular renal alterations. 
Morphology of human radiation nephropathy 
The kidney can be damaged either directly or indi-
rectly during therapeutic irradiation. Indirect injury may 
develop in patients receiving unilateral irradiation for an 
abdominal tumor (Fig. 1). Progressive myointimal pro-
liferation results in occlusive renal artery stenosis, lead-
ing to renovascular hypertension and a small atrophic 
kidney [37, 39, 60, 91, 117, 165, 171, 174, 192]. The 
hypertension can be cured by unilateral nephrectomy 
[39, 165, 174]. 
The morphologic details of direct radiation injury to 
the renal parenchyma were first described by Zuelzer et 
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Figure 5. A nephrectomy specimen showing radiation 
nephropathy in a 5-year-old child, 2 years after intraop-
erative irradiation (dose unknown) for neuroblastoma. 
Extensive mesangiolysis in one glomerulus (arrow) is 
present while the adjacent glomeruli appear largely un-
affected. Periodic acid-Schiff. Bar = 10 µm. 
al. in 1950 [210]. Although most examples of radiation 
nephropathy, when encountered on biopsy or at autopsy, 
are complex lesions, involving glomeruli, tubules and 
vessels, the glomerular component is generally regarded 
as the most important. In rare cases, in which biopsies 
have been taken relatively early in the clinical course of 
radiation nephropathy, glomerular lesions alone are pre-
sent, only later to be followed by tubulointerstitial and 
finally, vascular alterations [85, 86, 161]. The fine de-
tails of radiation nephropathy were first revealed in the 
ultrastructural study of Rosen et al. [160]; and confirm-
ed and refined in the subsequent literature [85, 86]. 
The most characteristic lesion observed in human 
radiation nephropathy affects the glomerulus. It is char-
acterized by a spectrum of abnormalities (Figs. 2 and 3) 
which range from necrotizing cellular injury with throm-
bosis, to structural alterations of the mesangial matrix 
and capillary loop basement membranes. The walls of 
the glomerular capillary loops exhibit a prominent thick-
ening, resulting from endothelial cell swelling and sepa-
ration of the endothelial cell (EC) from the basement 
membrane. Often, it is associated with reduplication of 
the basement membrane, resulting in a double contour, 
Radiation nephropathy 
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Figure 6. Experimental models of radiation nephropathy show the characteristic glomerulai- lesion (compare with 
Figure 2) characterized by segmental to global mesangiolysis (M) and subendothelial expansion. (A) Mouse, 15 Gy, 
12 months postirradiation (PI), hematoxylin and eosin, bar= 8 µm; (B) rat, 15 Gy, 20 weeks PI, periodic acid-Schiff, 
bar = 8 µm; (C) pig, 9.8 Gy, 12 weeks PI, periodic acid-Schiff, bar = 10 µm; (D) monkey, 35 Gy, 24 months PI, 
hematoxylin and eosin, bar = 10 µm. 
------------------------------------------------------------------------------------------
readily apparent by light microscopy with a silver stain 
(Figs. 2A and 2B). In its milder forms, this alteration 
may be visible only by electron microscopy (Fig. 3A). 
The mesangial areas also show prominent enlargement, 
with either an increase in matrix or, more characteristic-
ally, with a rarefaction of matrix, a process known as 
mesangiolysis (Fig. 2). This process can appear at times 
dramatic, with massive aneurysmal expansion of mesan-
gial areas. In addition, confluence of capillary loops or 
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florid expansion of the subendothelial space of the capil-
lary loops can result in marked compromise of the capil-
lary lumina (Fig. 2A). 
Glomerular capillary loop thrombosis and arteriolar 
thrombosis also may develop; with extension of the 
thrombotic phenomena, red blood cells and red cell frag-
ments are observed in the mesangial areas (Figs. 2C and 
3B). Although morphologically acute, this abnormality 
is rarely detected before 6-12 months postirradiation. 
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Figure 7. Glomeruli showing mesangiolysis and massive expansion of the subendothelial space (between arrows and 
S) with red blood cell extravasation and compromise of the capillary lumina (C). (A) Mouse, 15 Gy, 12 months PI, 
bar = 3 µm; and (B) pig, 9.8 Gy, 12 weeks PI, bar = 4 µm. 
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Ultrastructural studies show fibrin with very few inflam-
matory cells (Fig. JB), and necrosis of cellular ele-
ments, particularly ECs but also mesangial cells (MCs). 
By contrast, podocytes appear to be basically intact, al-
though they show variable effacement of their foot proc-
esses. Glomerular sclerosis characterized by mesangial 
sclerosis and collapse or obliteration of capillary loops, 
often devoid of mesangial and ECs, eventually develops 
in irreparably damaged glomeruli (Figs. 4A and 4B). 
These various lesions may affect either a portion of the 
glomerular tuft or the entire glomerular tuft and might 
co-exist within a single glomerulus. Moreover, not all 
glomeruli are necessarily affected in a uniform fashion. 
A severely damaged glomerulus may be adjacent to an 
apparently unaffected glomerulus (Fig. 5). 
Alterations of tubules and vessels and corresponding 
interstitial changes usually are a prominent finding, par-
ticularly since more examples of radiation nephropathy 
are encountered in the advanced stage. Atrophy of tu-
bules with thick and wrinkled basement membranes and 
adjacent interstitial fibrosis is invariable when renal 
insufficiency has developed. Accumulation of intimal 
foamy macrophages or intimal thickening due to myoin-
timal cell proliferation can develop in large and medium 
sized arteries (Fig. 1). Small arteries and arterioles 
might develop either medial hyperplasia or thrombosis 
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(Fig. 4A) with medial necrosis without a significant in-
flammatory response. The extent to which these tubular 
and vascular lesions represent a direct effect of radia-
tion, as opposed to confounding secondary contributions 
from hypertension and glomerulosclerosis, is unclear. 
Morphology of experimental radiation nephropathy 
The morphological expression of human radiation 
nephropathy, as outlined above, represents the advanced 
stages of the lesion, generally occurring when clinical 
signs of radiation injury are present, about 6-18 months 
after treatment. It has been amply demonstrated that the 
glomerular lesion, so characteristic of the human dis-
ease, also predominates in experimental models, thereby 
validating their use. Figures 6 and 7 demonstrate radia-
tion nephropathy produced in mouse, rat, pig, and mon-
key. There is variable capillary loop thickening with 
subendothelial expansion and basement membrane redup-
lication. The mesangium shows lysis of cells and matrix 
in continuity with the subendothelial space. Capillary 
loop collapse and mesangial sclerosis eventually develop. 
These experimentally induced glomerular lesions appear 
to develop regardless of the examined species (Table 1). 
Sequential studies of experimental radiation ne-
phropathy have revealed a variety of additional morpho-
logic alterations to capillary loops and mesangium in the 
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Figure 8 (at left) . Hyperchromatic enlarged nuclei (arrow) in a mouse glomerulus 7 months after irradiation with a 
single dose of 19 Gy. Hematoxylin and eosin. Bar = 10 µm. 
Figure 9 (at right). Nuclear enlargement (arrow) and a prominent lymphoid infiltrate (small dark nuclei; open arrow) 
in a pig glomerulus, 4 weeks after irradiation with a single dose of 9.8 Gy. Periodic acid-Schiff. Bar = 10 µm. 
------------------------------------------------- ---
Table 1. The morphologic features observed in the various components of the kidney following irradiation in different 
species. Figures in parentheses refer to the time after irradiation at which these changes have been observed. 
Species ... Mouse Rat 
Glomerular features 
nuclear enlargement +(> 3 months) 
inflammation 
mesangial proliferation 
mesangiolysis/thrombosis + (10 months) + (2-3 months) 
glomerulosclerosis + (10 months) + (2-3 months) 
Vascular features 
thrombosis - + (3 months) 
medial hyperplasia 
intimal thickening 
Tubular/interstitial features 
reactive changes + (6 months) + (6 weeks) 
tubulolys{~ months) + (6 weeks) + (4 weeks) 
tubular atrophy/ 
+ (6 months) + (2-3 months) interstitial fibrosis 
initial phases of radiation injury. Both mice and pigs 
show prominent nuclear enlargement in a subset of glo-
merular, presumably endothelial, cells [62, 64, 76, 110, 
111, 154, 159] (Figs. 8 and 9). Infiltration of glomer-
ular capillary loops by mononuclear cells, presumably 
lymphoid in nature, consistently occurs in pigs [76, 154] 
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Dog Pig Monkey Human 
+ (2 weeks) 
+ (2 weeks) 
+ (6 weeks) + (6 months) 
+ (2 months) + (3 months) + (6 months) + 
+ (3 months) + (5 months) + (6 months) + 
+ (4 months) + 
+ (2 months) + (3 months) + (6 months) + 
+ (6 months) + 
+ (2 weeks) + (6 weeks) + (4 months) + 
+ (2 months) + (3 months) + (4 months) + 
(Figs. 9 and 10). In addition, there are pronounced 
changes in the mesangium. Diffuse and severe mesangi-
al hypercellularity is observed in monkeys, but appears 
to be more focal in pigs (Figs. 11-15). In our experi-
ence, there is little evidence of mesangial hypercellular-
ity in mice or rats, although other studies have reported 
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Figure 10. An electron micrograph showing a lympho-
cyte (arrow) adherent to a glomerular capillary endothe-
lial cell (E). Pig, 9.8 Gy, 9 weeks PL Bar = 2 µm. 
Figure 11. Global mesangial hypercellularity in mon-
key, 44 Gy, 45 weeks PL Hematoxylin and eosin. Bar 
= 10 µm. 
Figure 12. Segmental mesangial hypercellularity 
(arrow) in pig, 9.8 Gy, 4 weeks PI. Hematoxylin and 
eosin. Bar = 12 µm. 
Figure 13. Electron micrograph depicting mesangial 
cell proliferation in pig, 9.8 Gy, 12 weeks PL Bar = 
5 µm. 
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increased MC proliferation [110, 112]. However, all 
species exhibit mesangial sclerosis. 
Although prominent mesangial and endothelial alter-
ations are observed consistently in radiation nephropa-
thy, the podocytes appear less affected. Focal lms of 
foot processes certainly develops. However, many glo-
meruli may show good retention of their foot processes 
Radiation nephropathy 
Figure 14 (at left). Electron micrograph showing mesangial matrix (M) increase (i.e., mesangial sclerosis). Compare 
with mesangiolysis seen in Figure 7 (C-capillary lumen). Pig, 9.8 Gy, 12 weeks PI. Bar = 2.5 µm. 
Figure 15 (at right). Electron micrograph showing segmental collapse of capillary loops (arrow) and subendothelial 
expansion (curved arrow). Pig, 9.8 Gy, 24 weeks PI. Bar = 2.5 µm. 
------------------------------------------------------------------------------
(Fig. 16). Denudation or necrosis of podocytes is not 
observed, even following capillary loop collapse or 
complete glomerulosclerosis. 
Both vascular and tubular interstitial injury contrib-
ute to the renal dysfunction clinically defined as radia-
tion nephropathy (Table 1). The respective contribution 
of these lesions and the role that irradiation plays in 
their development impart an additional layer of complex-
ity yet to be unraveled. It long has been recognized that 
the morphologic parameter in the majority of human re-
nal diseases most closely related to azotemia is tubulo-
interstitial disease [17, 52] . Although tubular atrophy 
may be a primary event in many diseases, atrophy invar-
iably ensues following glomerular sclerosis, regardless 
of the initial insult. Furthermore, hypertension has been 
shown to develop and presumably, to produce occlusive 
vascular lesions in irradiated kidneys. Both glomerular 
sclerosis and tubular atrophy can develop as a conse-
quence of hypertension [193]. Therefore, it is unclear 
to what extent radiation directly produces tubular or vas-
cular injury, since each may develop for other reasons. 
In early phases of radiation injury, small cortical 
foci of reactive appearing tubular epithelium is seen. 
These are characterized by nuclear enlargement, nuclear 
predominance, and basophilic cytoplasm (Fig. 17). In 
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advanced stages, tubular atrophy develops, characterized 
by small tubular cells enveloped by a thick, irregular 
basement membrane, which, in our experience, does not 
develop in the absence of significant glomerular altera-
tions. A distinctive subcapsular accentuation of these 
tubular alterations is prominent in pigs [154], and also 
has been reported in humans [85]. Although its distribu-
tion corresponds to a vascular pattern, the basis for the 
pattern is not clear. 
A third distinctive form of tubular injury develops 
in mice and rats; we have called this lesion tubulolysis. 
Here, there is apparent lysis of tubular cells [81, 110], 
leaving an empty or denuded profile of tubular basement 
membrane (Figs. 18 and 19). These tubules lack the 
thick, wrinkled basement membranes characteristic of 
atrophic tubules. Tubulolysis has not been observed in 
pigs or monkeys, nor has it been described in humans. 
In contrast, interstitial fibrosis with mild interstitial 
inflammation is a common feature of advanced disease 
in all species. 
Diverse vascular lesions develop in radiation ne-
phropathy. In humans, both thrombotic lesions in arte-
rioles (Fig. 4A) and arteries occur and intimal occlusive 
vascular lesions of large arteries (Fig. 1) can develop. 
Experimental animals demonstrate the same range of 
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Figure 16. Scanning electron micrographs of a pig glo-
merulus 24 weeks Pl 9.8 Gy, showing podocytes with 
intact foot processes (arrow; P: podocytes cell body). 
Bars = 10 µm (A) and 2.5 µm (B). 
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lesions, but show marked interspecies variation. Arteri-
olar and arterial thrombosis develops in parallel with 
glomerular thrombosis in both rats and monkeys (Figs. 
20 and 21), particularly at high radiation doses. 
Thrombotic lesions are very rare in mice, even follow-
ing high radiation doses, and have not been reported to 
develop in pigs. Occlusive but non-thrombotic vascular 
disease also develops in pigs, rabbits (166), dogs [125], 
and monkeys, but differs in the arterial layer affected. 
Pigs, rabbits, and dogs develop arteriolar and arterial 
medial hyperplasia. In pigs, medial hyperplasia devel-
ops only in the unilateral irradiation model; it is not evi-
dent in the bilateral irradiation model (Fig. 22). In con-
trast, monkeys develop occlusive intimal thickening 
without medial alterations (Fig. 23). However, rats and 
mice have not been reported to develop either of these 
chronic occlusive vascular lesions following kidney 
irradiation. 
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Pathogenesis 
Studies on the pathogenesis of radiation nephropathy 
have been plagued by controversy centered on the spe-
cific target cell(s) and pathophysiological mechanism(s) 
involved in the development of this lesion. Arguments 
have revolved around two opposing schools of thought 
concerning the primary site of renal injury, namely, vas-
cular versus parenchymal. Rubin and Casarett (162) 
proposed that the principal lesion was arterionephroscle-
rosis, with extra-glomerular vascular injury leading to 
vessel occlusion, ischemia, and secondary tubular atro-
phy and degeneration. However, arteriolar changes are 
an uncommon feature of experimental and clinical radia-
tion nephropathy [36) in the absence of systemic arterial 
hypertension. Indeed, arteriolar lesions are less severe 
as compared with tubular or glomerular lesions or may 
even be absent [202). Thus, the classical hypothesis that 
tubular degeneration occurs only secondary to injury of 
the vasculature and thrombosis is no longer tenable. 
Diametrically opposed to the vascular hypothesis is 
the parenchymal hypothesis, proposed by Withers et al. 
[203). Based upon observations of irradiated kidneys of 
a specific strain of inbred mice, they concluded that ra-
diation nephropathy results from tubule cell depletion 
alone. This hypothesis, a bench-mark in radiation biolo-
gy, served to stimulate a shift of emphasis from vascular 
injury as the sine qua non to explain the pathogenesis of 
late radiation injury per se. However, this hypothesis 
ignores the wealth of data not only from experimental 
studies involving a variety of species including other 
murine strains [34, 62, 64, 129, 159), but also from 
clinical studies involving localized [85, 86, 160, 161) or 
TBI [9, 33, 73, 75, 188) that show glomerular damage 
occurring either before or concomitantly with the devel-
opment of tubular damage. Although it is certainly the 
case that proximal tubule epithelial cells are radiosensi-
tive, with cell loss being evident within several weeks of 
irradiation, they are not the only target cells involved in 
the development of radiation nephropathy. Thus, the 
classical view that radiation nephropathy involves vascu-
lar or parenchymal cell loss alone is simplistic. 
In recent years, the characteriz.ation of radiation-in-
duced normal tissue morbidity has undergone a paradig-
matic shift. Pathophysiological data from a variety of 
late-responding normal tissues indicate that the expres-
sion of radiation-induced normal tissue injury involves 
complex and dynamic interactions between several cell 
types within a particular organ [76, 163, 170). These 
cells are viewed now not as passive observers, merely 
dying as they attempt to divide, but rather as active 
participants in an orchestrated response to injury. The 
central dogma of radiation biology, in which irradiation 
causes damage to DNA, leading to death of the cell 
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when it attempts to divide, now is seen as only one part 
of the overall picture. Ionizing radiation appears to 
cause a marked alteration in the phenotype of cells, due 
to activation of transcription and signal transduction 
pathways. Thus, in vitro, radiation has been shown to 
activate early-response genes, such as c-jun, Egr-1, 
c-fos, and NFKB (for review see [195]) via activation of 
kinases including protein kinase C and tyrosine kinase. 
The products of these early response genes may serve to 
regulate downstream genes, such as cytokines and 
growth factors that could play a role in cell and organ 
response to radiation injury. The importance of this new 
paradigmatic approach to radiation-induced morbidity, 
and specifically, radiation nephropathy, is that research 
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Figure 17. Deep cortical medullary ray of a pig show-
ing reactive tubular epithelium, a cell in mitosis (arrow), 
and interstitial edema. 9. 8 Gy, 6 weeks PL Periodic 
acid-Schiff. Bar = 10 µm. 
Figure 18. Tubulolysis (arrows) in mouse characterized 
by total disappearance of tubular cells leaving naked tu-
bular basement membranes. 15 Gy, 12 months PL He-
matoxylin and eosin. Bar = 15 µm. 
Figure 19. Electron micrograph of mouse kidney show-
ing tubulolysis (arrows). 15 Gy, 12 months PL Bar = 
10 µm. 
is now being directed to consider the radiation response 
of the various cell types in terms not solely of survival, 
but also of altered cellular behavior. 
To fully understand the pathogenesis of radiation ne-
phropathy, it is necessary to consider the response of, 
not one, but several cell types. We propose that these 
are primarily the glomerular capillary ECs and MCs, 
and, albeit to a lesser extent, the proximal tubule epithe-
lium. The morphologic and functional data presented in 
this review suggest that glomerular capillary endothelial 
cell damage represents an important primary event in re-
nal radiation injury. Radiation-induced increases in the 
labeling index of these cells occur within two weeks of 
radiation [156], confirming that the microvascular ECs 
appear to be the most radiosensitive of the vascular wall 
components [146]. Although the direct effects of radia-
tion on glomerular capillary EC function and/or func-
tional changes resulting from cell loss remain ill-defined, 
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Figure 20. Arterial (arrow), arteriolar, and glomerular 
thrombosis, segmental glomerular sclerosis, and severe 
tubular atrophy (open arrow) in a mouse kidney. 19 
Gy, 12 months PL Periodic acid-Schiff. Bar = 15 µm. 
Figure 21. Arteriolar (arrow) and glomerular capillary 
thrombosis (curved arrow) in a monkey kidney. 44 Gy, 
45 weeks PL Periodic acid Schiff. Bar = 15 µm. 
Figure 22. Pig kidney showing medial hyperplasia of 
both arteries and arterioles (arrow) in the peripheral cor-
tex associated with glomerulosclerosis (curved arrow) 
and tubular atrophy. 9.8 Gy, 20 weeks PI. Periodic 
acid-Schiff. Bar = 20 µm. 
one of the earliest morphological changes appears to be 
the attachment of leukocytes to the glomerular capillary 
endothelium [76). Endothelial cells irradiated in vitro 
release a chemotactic factor, which appears to be a lipid 
product of the lipoxygenase pathway [ 49]. Furthermore, 
irradiation has been shown to modulate EC/leukocyte in-
teraction by causing a marked release of 13-hydroxyoc-
tadecadienoic acid (13-HODE) [21], a chemorepellant 
believed to act as an internal regulator influencing the 
expression of adhesive molecules on the EC surface 
[22]. Thus, radiation may cause increased production of 
EC-derived chemoattractants, reduction in EC-derived 
chemorepellants, and loss of down-regulation of the cell 
adhesion surface, effectively promoting endothelial/leu-
kocyte interaction. This event also may reflect a radia-
tion-induced increase in the synthesis and/or upregula-
tion of endothelial surface leukocyte adhesion molecules, 
Radiation nephropathy 
such as E-selectin and ICAM-1 [173). Radiation-in-
duced activation of adhesion molecules in vitro has been 
reported following radiation of normal and malignant 
glial cells and human cerebral microvascular ECs [207; 
Brayton et al., unpublished observations]. Furthermore, 
glomerular capillary ECs often appear swollen with the 
appearance of increased metabolic activity at this time, 
an appearance which is associated with endothelial acti-
vation [140). 
In addition, radiation appears to cause a profound 
increase in the permeability of the glomerular capillary 
endothelium, as evidenced by both transudation and emi-
gration of plasma and red blood cell components into the 
subendothelial and mesangial compartments. These 
events lead to marked pericapillary edema and reduction 
in lumen cross-sectional diameter. It is of interest to 
note that experimental [57, 76, 110) and clinical studies 
[86) suggest that the podocytes appear relatively unaf-
fected at this time; the minimal degree of proteinuria 
found at these times is consistent with this observation. 
These findings suggest radiation-induced glomerular EC 
damage without either concomitant basement membrane 
damage or altered permeability; irradiation of ECs in 
vitro is associated with increased transendothelial move-
ment of albumin [184). This subendothelial widening 
also may represent loss of adhesive interaction between 
the EC and the glomerular basement membrane via al-
tered integrin expression. Integrins are a family of ma-
trix receptors [2] that play an important role in cell-cell 
and cell-matrix interaction in several systems, including 
the kidney [1). lmmunoelectron microscopic studies of 
human kidney have demonstrated increased density of {31 
integrins on the portion of glomerular capillary EC fac-
ing the glomerular basement membrane [87). Further-
more, integrin antibodies alter EC permeability proper-
ties and their capacity to retain macromolecules [100). 
Radiation might cause a loss of these receptors, with 
subsequent loss of cell-cell adhesion and increased per-
meability, leading to marked widening of the subendo-
thelial space. At present, such a proposal is purely 
speculative, and requires experimental verification. 
These alterations in glomerular EC permeability and 
subendothelial transudation occur concomitantly with a 
significant reduction in GFR [76), indicating a possible 
causative relationship. However, the regulation of glo-
merular capillary hemodynamics and filtration is multi-
farious. Both glomerular ECs and MCs elaborate and 
respond to a host of vasoactive factors important in reg-
ulating capillary hemodynamic and filtration properties. 
These include prostacyclin (PGI2), nitric oxide, and en-
dothelin [138). The mesangium, by virtue of its con-
tractile properties, is intimately involved in the regula-
tion of glomerular blood flow. As such, it responds di-
rectly or indirectly to circulating and locally synthesized 
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Figure 23. Monkey kidney showing florid arterial 
occlusive intimal thickening (arrow) without medial 
alterations. 44 Gy, 23 weeks Pl. Hematoxylin and 
eosin. Bar = 10 µm. 
vasoactive substances such as angiotensin II (All), vaso-
pressin, platelet activating factor (P AF), thromboxane 
A2 (TXA2), and prostaglandin Bi by contraction, and re-
sults in reduced glomerular filtration surface area and ul-
trafiltration coefficient [167). In response to All and 
vasopressin, mesangial cells also produce PGI2, which 
causes mesangial relaxation and may modulate contrac-
tility [187). 
A radiation-induced reduction in PGI2 production 
has been observed in vitro [3] and in vivo [172), possi-
bly reflecting damage to the enzymatic machinery re-
quired for PGI2 production [50). Renal irradiation, as 
either localized [196) or TBI [168) leads to excessive 
levels of TXA2, resulting in increased vasoconstriction. 
Excess TXA2 production also will render the endotheli-
um more thrombogenic. Thus, the microthrombi seen 
in more severe radiation nephropathy may further reflect 
radiation-induced perturbations in EC eicosanoid metab-
olism. 
These initial, primarily EC alterations, are aug-
mented at later times by a progressive mesangial in-
volvement, evidenced by mesangial hyperplasia and/or 
hypertrophy with increased matrix formation. This leads 
to progressive obliteration of glomerular capillaries and 
sclerosis, and appears to play a key role not only in ra-
diation nephropathy, but also in other forms of chronic 
renal injury [74, 90, 143]. Mesangial proliferation may 
occur in response to a variety of growth factors and 
cytokines released by injured or stimulated ECs, podo-
cytes, and MCs themselves, as well as infiltrating cells 
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and platelets [186]. Although there is, as yet, no infor-
mation available regarding the effect of radiation on 
MCs, irradiation has been shown in vitro to cause re-
lease of mitogens from ECs, including platelet-derived 
growth factor and fibroblast growth factor-like sub-
stances [49). Renal irradiation also leads to tubular 
damage. This may result from direct radiation-induced 
cell kill, may in part be secondary to the initial glomeru-
lar injury, and may reflect the presence of significant 
extraglomerular lesions. 
Radiation, thus, damages both glomerular and tubu-
lar components. The resulting lesions will interact and 
will further exacerbate the overall pathology. Associ-
ated with these changes will be the added complication 
of late vascular damage, resulting in secondary ischemic 
insult and the possible development of hypertension 
[199). Moreover, the progressive nature of the glomer-
ular lesion likely leads to hypertrophy and hyperfiltration 
by the remaining nephrons. Both processes have been 
reported to cause additional glomerular injury [6, 54). 
The kidney becomes locked in a pathogenic circle of in-
creasing nephron loss and damage, the end results of 
which are destruction of the renal parenchyma, glomeru-
losclerosis, and ultimate renal failure. 
In summary, although the specific pathogenic mech-
anisms involved remain to be defined, the classic view 
that radiation nephropathy involves either vascular or 
parenchymal cell loss alone is clearly oversimplistic. 
The renal response to irradiation is essentially identical 
to that observed in a number of chronic progressive 
nephropathies; no pathognomonic characteristics can be 
identified in the irradiated kidney. The resultant clinical 
expression of damage in the kidney involves complex 
and dynamic interactions between the various cell types. 
The lesion appears to be predominantly glomerular in 
nature. 
What direction does research in this area need to 
take? Clearly normal renal function is the result of pre-
cise and complex interactions between the various cell 
types. Specific biomolecules produced by the cells regu-
late cellular interaction and function via paracrine and 
autocrine mechanisms, ensuring the maintenance of 
function in the face of alterations to the cellular environ-
ment. Irradiation leads to both cell loss and injury. In 
the past, studies of radiation nephropathy, and indeed re-
nal disease per se, were limited to various pharmacologi-
cal mechanisms of injury, combined with assessment of 
the histologic and physiological consequences. Ad-
vances in molecular biology over the last few years have 
opened up an exciting new avenue of research in renal 
pathophysiology. Cellular injury leads to alterations in 
gene expression, e.g., upregulation of genes regulating 
repair and regeneration. Techniques are now available 
to investigate the location, structure, activity, regulation 
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of production, and mechanism of action of these gene 
products [132). Activated genes can be identified by the 
presence of increased messenger RNA and their specific 
protein products. The application of these powerful 
techniques to probe radiation-induced alterations in glo-
merular capillary EC and MC function is likely to pro-
vide significant insight into the pathogenic mechanism(s) 
involved in the development of radiation nephropathy. 
Such mechanistic data will provide clues to developing 
rational interventional procedures for the successful 
amelioration of clinical radiation nephropathy. 
Influence of Dose Fractionation on the 
Radiation Tolerance of the Kidney 
Clinically, the kidney is viewed as a radiosensitive 
organ, a total dose of 20 Gy being considered the upper 
limit of radiation "tolerance" [95). This dose has been 
adopted somewhat arbitrarily, having been applied over 
a broad range of dose fractionation schedules. Experi-
mental studies have indicated that the kidney has an ex-
tensive capacity for repair of sublethal radiation damage; 
the size of the dose of fractionated radiation markedly 
influences the total tolerance dose [61, 68, 151, 179, 
180, 201]. There is a marked increase in the tolerance 
dose with decreasing size of the dose per fraction. 
Renal fractionation data can be analyzed using the LQ 
formula [44, 56): 
E = n(ad + fJd2) (1) 
where the effect (E) is a linear and quadratic function of 
the dose per fraction ( d) and a function of the fraction 
number (n) . This equation allows determination of the 
a/fl ratio, a direct measure of the extent of curvature or 
elasticity of the underlying cell survival curve. General-
ly, experimental kidney fractionation data have been well 
described by the LQ model, with most studies indicating 
an a/fl ratio of2-3 Gy [81, 179, 180, 190, 201), a value 
typical of a late responding normal tissue. However, a 
value of around 5 has been reported in the irradiated 
mouse kidney, determined in terms of surviving tubule 
cells assessed 19 months after irradiation [77). 
At doses of < 1-2 Gy per fraction, major deviations 
from the renal tolerance values predicted by the LQ 
model were noted [180). This, in part, may reflect in-
complete repair of sublethal damage between fractions, 
since short interfraction intervals of 5 hours were used. 
However, a reduction in repair capacity after multiple 
irradiations, due to diminished induction of molecular 
repair mechanisms [78) or the presence of a small popu-
lation of radiosensitive cells, cannot be excluded. 
Reirradiation and residual injury 
The recurrence of a primary tumor or metastatic 
spread might necessitate the re-irradiation or retreatment 
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of a previously irradiated volume, which included the 
kidney. It has been suggested that renal reirradiation 
can be considered, since parenchymal cell depletion was 
negated by the repopulation of the tubules by surviving 
clonogens [203] . However, experimental studies refute 
thishypothesis[153, 158,178,181,182,183]. Studies 
of retreatment tolerance in the kidney indicate the virtual 
absence of any long-term recovery. Retreatment of the 
kidney appears to add to a slowly developing initial le-
sion, causing a more rapid expression of previously sub-
clinical injury. This occurs despite apparent evidence 
for tubular regeneration [137, 154]. This tubular regen-
eration might be insufficient to match the rate of cell 
loss following irradiation. In addition, tubular prolifera-
tion might occur without a corresponding organization 
into functionally patent nephrons [182]. The lack of 
recovery also may reflect the predominant role of the 
glomerulus in the development of radiation nephropathy. 
As discussed above, the glomerular lesions observed 
following radiation are progressive, with no evidence of 
recovery. 
All these hypotheses require further experimental 
investigations before definite conclusions can be drawn. 
One should note that, whatever the underlying mecha-
nisms involved, the kidney fail s to exhibit complete 
Jong-term recovery of function following irradiation. 
Thus, reirradiation of the kidney in patients should be 
undertaken with extreme caution, if not avoided al-
together. 
Treabnent of Radiation Nephropathy 
The incidence and severity of radiation nephropathy 
obviously can be reduced by limiting the volume of renal 
tissue irradiated and/or the amount of total dose adminis-
tered. Indeed, renal shielding has successfully reduced 
the incidence of renal dysfunction in BMT patients 
receiving TBI [102]. However, any reduction in total 
radiotherapeutic dose clinically employed carries with it 
the risk of compromising tumor cell kill . An alternative 
approach utilizes the application of interventional pro-
cedures directed at a selective reduction in radiation-
induced renal morbidity. This approach, if successful, 
will increase the threshold dose for radiation nephropa-
thy and result in a clinically significant increase in thera-
peutic gain. Until recently, all chronic radiation-induced 
normal tissue morbidity was viewed to be progressive 
and essentially untreatable. However, the characteriza-
tion of radiation-induced normal tissue injury has under-
gone a paradigmatic shift. The increasing awareness 
that such morbidity is not simply a consequence of a 
reduction in cell number of a particular target cell popu-
lation, but rather the result of complex and dynamic 
interactions between particular cell types, has stimulated 
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research in this area. 
Although the successful protection of the irradiated 
kidney with renal arterial infusion of adrenaline has been 
reported clinically [175], the invasive nature of the tech-
nique precludes extensive use of such a procedure. Ste-
roids have been reported to provide some symptomatic 
help [169], but did not appear to modify the progressive 
renal insufficiency. Although initial experimental data 
indicated that such treatment potentiated radiation effects 
on the renal vasculature [13, 25], this is now thought to 
reflect the high doses of steroids which were employed. 
More recent studies, using more appropriate doses, have 
shown significant attenuation of functional and morpho-
logic parameters of radiation nephropathy in the rat and 
thus, have been associated with a significant increase in 
long-term survival [58, 59]. Placing the patient on a 
low protein diet may be helpful [114, 162]. A scientific 
rationale for the clinical use of low protein diets has 
come from recent studies on the consequences of re-
duced nephron number. This will lead to compensatory 
glomerular hypertrophy and/or hyperfiltration in the 
remaining nephrons that lead to further progressive glo-
merulosclerosis [20]. Low protein diets, which prevent 
or at least attenuate this compensatory response, have 
proven experimentally successful in reducing the severity 
of progressive glomerular injury [69]. Dietary protein 
restriction indeed can ameliorate the severity of radiation 
nephropathy in the rat [112, 113] and pig [155]. How-
ever, it remains to be determined whether such an inter-
ventional procedure will offer the prospect of significant 
clinical benefit. 
Ongoing research into the pathogenesis and modula-
tion of renal injury has provided exciting mechanistic in-
sights into the renal response to injury. These advances 
have allowed researchers both to reevaluate their hypoth-
eses regarding the pathogenesis of radiation nephropathy 
and to propose novel approaches to the future treatment 
of radiation nephropathy. 
The Renin angiotensin system (RAS) Arruda [10] 
first suggested that irradiation-induced damage to the re-
nal vasculature led to renal ischemia, renin release, in-
creased All production, and hypertension. As discussed 
above, the lack of significant vascular injury occurring 
as a primary event in radiation nephropathy led to a re-
vision of this hypothesis. Thus, Robbins and Hopewell 
[147] hypothesized that radiation caused a relative renal 
cortical ischemia, which appeared to be mediated via the 
RAS; the angiotensin-converting enzyme inhibitor 
(ACEI) captopril abrogated the early radiation-induced 
decreases in GFR and ERPF in the pig. However, later 
studies failed to demonstrate a radiation-induced in-
creased in plasma renin levels [80, 149]; the role of the 
RAS in radiation nephropathy appeared to be minimal. 
This negative conclusion was reached in view of the 
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dogma regarding the RAS; renin is produced and stored 
in the kidney and is released into the blood where AI is 
generated, and the latter is converted to AIi by ACE 
present in the pulmonary vasculature. However, renin, 
AI, and AIi now have all been identified in the juxtaglo-
merular cells [72]. Moreover, angiotensinogen has been 
detected as both mRNA and active protein in the rat kid-
ney [26, 122] indicating the likelihood of intrarenal pro-
duction of AIi. Thus, localized production of AIi may 
occur independently of changes in circulating renin. 
Evidence supporting this active involvement of AIi in 
the pathogenesis of radiation nephropathy has come from 
more recent studies using the ACEI captopril. This 
compound has proven to be remarkably effective in the 
treatment of a variety of chronic experimental [7, 15, 
197] and clinicalnephropathies [70,104, 141]. Clearly, 
captopril can reduce the severity of radiation nephropa-
thy arising from both localized kidney irradiation [24, 
32, 147] and TBI [126]. However, its mode of action 
is unresolved. Studies with other non-thiol ACE inhibi-
tors have indicated that the thiol group of captopril is not 
essential for its renal action [83, 127]. Thus, its benefi-
cial action appears to involve inhibition of All produc-
tion. It should be noted that some of the beneficial ac-
tions of ACEI could reflect accumulation ofkinins, since 
the ACEI is also kininase II. The advent of a new class 
of orally active All receptor blockers has allowed the 
role of AIi in renal disease to be further delineated [99, 
205]. Determining the therapeutic efficacy of such 
agents in the treatment of radiation nephropathy is 
eagerly awaited. 
Possible mechanisms to explain the efficacy of cap 
topril have centered on the drug acting primarily to 
block the hypertensive action [7] and/or the trophic ac-
tion of Agll [54, 55]. In addition to its role in modulat-
ing renal hemodynamics, it has become apparent that 
AIi plays an equally important role in the regulation of 
renal cell growth. AIi can be considered to be a renal 
cytokine, binding to specific cell surface receptors, 
activating several signal transduction pathways associated 
with cell growth, and inducing cell proliferation [131, 
204]. In view of the central role of mesangial sclerosis 
in radiation nephropathy, it should be noted that AIi 
effects on mesangial cells include mesangial cell hyper-
trophy and hyperplasia [131, 204], upregulation of extra-
cellular matrix genes [164], activation of early growth 
genes [128], and generation of inflammatory mediators 
and other growth factors [164]. These observations, 
although speculative, appear to indicate a major role for 
AIi in the pathogenesis of radiation nephropathy, thereby 
warranting further study. 
Transforming growth factor {J Any specific ac-
tions of AIi in the irradiated kidney would likely be 
modulated via dynamic interactions with other renal 
cytokines. Again, although there are few data yet avail-
able from models of radiation nephropathy, particular 
growth factors appear very interesting. The role of 
transforming growth factor beta (TGF-,B) in increased 
mesangial matrix production is well documented [133, 
206]. The successful blocking of renal TGF-,B activity 
using antibodies [18] or the proteoglycan decorin [19], 
a natural regulator of TGF-,B, results in suppression of 
renal injury. A similar strategy may be of potential use 
in radiation nephropathy. It is interesting to note that 
the beneficial effect of dietary protein restriction in 
reducing the severity of radiation nephropathy [112, 
113, 155] can be explained, in part, by the ability of 
protein restriction to downregulate TGF-,B expression, 
thereby preventing increased glomerular extracellular 
matrix production [134]. Although there are no data as 
yet to show increased production of TGF-,B in the irradi-
ated kidney, abnormal radiation-induced TGF-/3 produc-
tion has been causally linked to the development of 
radiation fibrosis in the skin [27, 116], lung [163], and 
liver [8]. Irradiation of mesangial cells in vitro does 
appear to cause upregulation of mRNA TGF-,B produc-
tion (Robbins, unpublished observations). The recent 
finding that AIi induces the synthesis of TGF-,B in 
smooth muscle cells in vitro [164] suggests that irradia-
tion-induced changes in MC activity may reflect an 
ongoing interaction between All and TGF-/j. 
Antioxidant enzymes Advances in understanding 
the role of renal antioxidant enzymes in the pathogenesis 
of reactive oxygen species (ROS)-induced renal injury 
suggest that the therapeutic benefit of corticosteroids in 
models of ROS injury may reflect, in part, a corticoste-
roid-induced upregulation of glomerular antioxidant 
enzymes [71, 208]. A potential role for ROS in the 
- pathogenesis of radiation nephropathy is suggested by 
the presence in the irradiated kidney of mesangiolysis, 
a lesion observed in ROS models of renal injury [185]. 
A corticosteroid-induced upregulation of antioxidant en-
zymes would provide a rationale for the reported benefit 
of this therapy in attenuating radiation nephropathy in 
the rat [54, 55]. 
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Thus, there are a number of potential interventional 
therapies that could prove to be beneficial in the treat-
ment of radiation nephropathy. Further research is 
needed to establish whether any of these will prove ulti-
mately to be clinically applicable. At present, patients 
presenting chronic radiation nephropathy and hyperten-
sion should be treated aggressively with antihyperten-
sives; low protein diets may be useful in preventing glo-
merular hyperfiltration and hypertrophy. Renal dialysis 
or transplantation may be practicable in a patient with 
severe bilateral involvement. In general, the irradiated 
kidney should be managed by a reduction in its function-
al load. It may well be that the function in all irradiated 
Radiation nephropathy 
kidneys is compromised to varying degrees. Exposure 
of the irradiated kidney to any additional nephrotoxic 
insult should be viewed with extreme caution. 
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Discussion with Reviewers 
A.P. Evans: What types of studies should be performed 
to better understand the mechanisms of radiation injury 
in the kidney? In other words, what clinical or experi-
mental information is lacking concerning the mecha-
nisms of radiation injury? 
Authors: Although the predominant role of the glomer-
ular capillary endothelial cell and the mesangial cell has 
clearly been recognized, there is essentially no informa-
tion available regarding the cellular response of these 
cells to irradiation. Studies need to be directed at prob-
ing radiation-induced alternations in gene expression by 
the use of molecular biology techniques using both in 
vitro and in vivo techniques. Such mechanistic data will 
allow the development of interventional procedures 
directed at ameliorating the severity of radiation 
nephropathy. 
J.B. Reitan: Different cell types react differently to 
fractionation of radiation dose in radiotherapy, and tissue 
interaction of cell types is often overlooked in radiation 
pathogenesis. The appearance of radiation nephropathy 
may be another than the "classic" if different fractiona-
560 
tion than the ordinary 1. 8-2 Gy per fraction per day is 
applied. Can the uncertainty regarding the relative 
importance of glomerular/vascular and tubular effects be 
due to differences in fractionation? Is there any indica-
tion from your data or literature that hyperfractionation 
(smaller doses per fraction) can reduce the nephropathy 
problem? 
Authors: We would argue that there is little uncertainty 
regarding the primary site renal injury in the irradiated 
kidney. The data presented in this review clearly dem-
onstrate that the lesion is primarily glomerular in nature. 
There is no data to suggest that altering the fractionation 
response has any significant effect in terms of altering 
the pattern of the functional or morphological changes 
seen in the irradiated kidney. While hyperfractionation 
clearly results in significant sparing of the kidney, due 
to its extensive capacity to repair sublethal injury, such 
regimens still lead to the development of radiation 
nephropathy in some BMT patients. The kidney remains 
a significant dose-limiting normal tissue in radiotherapy. 
V.H. Gattone: Total body irradiation (TBI) has become 
prominent in the clinical setting of bone marrow trans-
plant. Based on your review of the literature, would 
you expect to see more favorable or detrimental renal 
picture after TBI in pediatric patients, especially young 
patients? 
Authors: It is unlikely that a more favorable renal pic-
ture would be seen after TBI in pediatric patients. On 
the other hand, the clinical evidence for the presence of 
an age-effect with regard to increased susceptibility to 
renal injury following TBI remains equivocal. Although 
the best descriptions of TEI-induced nephropathy con-
cern pediatric populations [9, 188], this might reflect 
closer follow up of these patients, rather than increased 
susceptibility of the growing kidney. Other studies have 
failed to show an age-effect; Lonnerholm et al. [105] 
reported renal dysfunction in 4/22 autografted children 
(18%) compared with 8/50 (16%) adults. Several fea-
tures of radiation nephropathy suggest a careful evalua-
tion of renal function in the young patient after TBI. 
The lesion is chronic, loss of renal function appears pro-
gressive, there is little significant long-term recovery of 
function. Improvements in cancer therapy and enhanced 
long-term survival of pediatric TBI patients reinforce the 
need for such data. Any additional nephrotoxic insult 
following TBI should be avoided if possible. 
